Author:
Camilleri Michael,Saito Yuri A.
Reference94 articles.
1. Roden, D. M., Altman, R. B., Benowitz, N. L., et al. (2006) Pharmacogenomics: challenges and opportunities. Ann. Intern. Med. 145, 749–257.
2. Locke, G. R., III, Taller, N. J., Fett, S. L., Zinsmeister, A. R., and Melton, L. J., III. (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 112, 1448–1456.
3. Kurata, J. H., and Nogawa, A. N. (1997) Meta-analysis of risk factors for peptic ulcer. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and smoking. J. Clin. Gastroenterol. 24, 2–17.
4. Pounder, R. E., and Ng, D. (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment. Pharmacol. Ther. 9, 33–39.
5. Marshall, B. J., Goodwin, C. S., Warren, J. R., et al. (1988) Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 2, 1437–1442.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献